Back to Search Start Over

Aldeyra's dry eye drops make another clinical splash as the company nears NDA submission.

Authors :
Bayer, Max
Source :
FierceBiotech; 7/12/2022, pN.PAG-N.PAG, 1p
Publication Year :
2022

Abstract

Aldeyra's dry med was successful in a crossover trial, another clinical win as the company nears a formal approval submission. [ABSTRACT FROM AUTHOR]

Subjects

Subjects :
DRY eye syndromes
CROSSOVER trials

Details

Language :
English
Database :
Complementary Index
Journal :
FierceBiotech
Publication Type :
Periodical
Accession number :
157961154

Tools

Authors Abstract Subjects Details